Home Repository Download Help About Statistics Taxonomy Blastx
Links
PULDB
CAZy
dbCAN2
dbCAN-seq
run_dbcan
CAZypedia
PlantCAZyme
Cite: NAR/gkaa742 2020



PUL General Information

Literature Information

PUL ID

PUL0295

PubMed

29310579, BMC Genomics. 2018 Jan 8;19(1):33. doi: 10.1186/s12864-017-4388-9.

Characterization method

gene trait matching exercise

Genomic accession number

NZ_PJEF01000016.1

Nucelotide position range

18122-45020

Substrate

arabinan

Loci

APC1462_RS10100-APC1462_RS10145

Species

Bifidobacterium longum/216816

Degradation or Biosynthesis

degradation

Gene Name

Locus Tag

Protein ID

Gene Position

GenBank Contig Range

EC Number

- APC1462_RS10100 WP_007057459.1 0 - 1482 (+) NZ_PJEF01000016.1:18122-19604 -
- APC1462_RS10105 WP_007054095.1 1487 - 1730 (-) NZ_PJEF01000016.1:19609-19852 -
- APC1462_RS10110 WP_049135723.1 1746 - 2946 (+) NZ_PJEF01000016.1:19868-21068 -
- APC1462_RS10115 WP_100970046.1 3126 - 8121 (-) NZ_PJEF01000016.1:21248-26243 -
- APC1462_RS10120 WP_069483974.1 8247 - 14250 (-) NZ_PJEF01000016.1:26369-32372 -
- APC1462_RS10125 WP_032741659.1 15137 - 18878 (-) NZ_PJEF01000016.1:33259-37000 -
- APC1462_RS10130 WP_069483975.1 19121 - 22415 (-) NZ_PJEF01000016.1:37243-40537 -
- APC1462_RS10135 WP_007052960.1 22761 - 25959 (-) NZ_PJEF01000016.1:40883-44081 -
- APC1462_RS10145 WP_007056973.1 26293 - 26899 (-) NZ_PJEF01000016.1:44415-45021 -

Cluster number

1

Gene name

Gene position

Gene type

Found by CGCFinder?

- 1 - 1482 (+) TC: gnl|TC-DB|P15993|2.A.3.1.3 Yes
- 1488 - 1730 (-) other Yes
- 1747 - 2946 (+) other Yes
- 3127 - 8121 (-) CAZyme: GH43_22|GH43_34|GH43 Yes
- 8248 - 14250 (-) CAZyme: GH43_22|GH43_26|GH43 Yes
- 15138 - 18878 (-) CAZyme: GH43_27|GH43 Yes
- 19122 - 22415 (-) CAZyme: GH43_22|GH43 Yes
- 22762 - 25959 (-) CAZyme: GH43_22 Yes
- 26294 - 26899 (-) TC: gnl|TC-DB|E4R229|9.B.28.1.3 Yes

PUL ID

PUL0295

PubMed

29310579, BMC Genomics. 2018 Jan 8;19(1):33. doi: 10.1186/s12864-017-4388-9.

Title

Gene-trait matching across the Bifidobacterium longum pan-genome reveals considerable diversity in carbohydrate catabolism among human infant strains.

Author

Arboleya S, Bottacini F, O'Connell-Motherway M, Ryan CA, Ross RP, van Sinderen D, Stanton C

Abstract

BACKGROUND: Bifidobacterium longum is a common member of the human gut microbiota and is frequently present at high numbers in the gut microbiota of humans throughout life, thus indicative of a close symbiotic host-microbe relationship. Different mechanisms may be responsible for the high competitiveness of this taxon in its human host to allow stable establishment in the complex and dynamic intestinal microbiota environment. The objective of this study was to assess the genetic and metabolic diversity in a set of 20 B. longum strains, most of which had previously been isolated from infants, by performing whole genome sequencing and comparative analysis, and to analyse their carbohydrate utilization abilities using a gene-trait matching approach. RESULTS: We analysed their pan-genome and their phylogenetic relatedness. All strains clustered in the B. longum ssp. longum phylogenetic subgroup, except for one individual strain which was found to cluster in the B. longum ssp. suis phylogenetic group. The examined strains exhibit genomic diversity, while they also varied in their sugar utilization profiles. This allowed us to perform a gene-trait matching exercise enabling the identification of five gene clusters involved in the utilization of xylo-oligosaccharides, arabinan, arabinoxylan, galactan and fucosyllactose, the latter of which is an abundant human milk oligosaccharide (HMO). CONCLUSIONS: The results showed high diversity in terms of genes and predicted glycosyl-hydrolases, as well as the ability to metabolize a large range of sugars. Moreover, we corroborate the capability of B. longum ssp. longum to metabolise HMOs. Ultimately, their intraspecific genomic diversity and the ability to consume a wide assortment of carbohydrates, ranging from plant-derived carbohydrates to HMOs, may provide an explanation for the competitive advantage and persistence of B. longum in the human gut microbiome.